Esophageal Squamous Cell Carcinoma Clinical Trials in Guangzhou
3 recruitingGuangzhou, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li426 enrolled5 locationsNCT05043688
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Shandong Boan Biotechnology Co., Ltd510 enrolled1 locationNCT06022861
Recruiting
Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody
Esophageal Squamous Cell CarcinomaPD-1 Inhibitor
Nanfang Hospital, Southern Medical University200 enrolled1 locationNCT05392413